Davis-based biotech firm Arcadia Biosciences Inc. says it has received a nearly $2 million award from the U.S. National Institutes of Healths Diabetes and Digestive and Kidney Disorders Institute to develop reduced-gluten grains.
Arcadia said its internal research team will collaborate with Karol Sestak, associate professor of microbiology and immunology at Tulane University.
Concern about the health effects of gluten is of increasing importance to global consumers and is a rapidly growing market for food manufacturers, said Eric Rey, president and CEO of Arcadia. The goal of our reduced-gluten grains research program is to develop wholesome grains that provide a wider range of food choices for people with gluten-intolerance and celiac disease.
Call The Bees Mark Glover, (916) 321-1184.